Results 171 to 180 of about 298,517 (337)

Coreceptor Utilization by Human Immunodeficiency Virus Type 1 Is Not a Primary Determinant of Neutralization Sensitivity [PDF]

, 1998
Rachel LaCasse, Kathryn E. Follis, Tarsem Moudgil, Meg Trahey, James Μ. Binley, Vicente Planelles, Susan Zolla‐Pazner, Jack H. Nunberg   +7 more
openalex   +1 more source

Clinical effectiveness and treatment satisfaction between two triple‐therapy regimens in treating neuropathic pain: A real‐world data

Ibrain, EarlyView., 2023
This study compared the clinical effectiveness and treatment satisfaction of Pregabalin and Gabapentin triple therapy for neuropathic pain in a real‐world setting. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from baseline to 12 weeks posttreatment.
Nithya Raju, Samyuktha Villavan, Saranya Ravi, Roja Murugesan, Panneerselvam Theivendren, Vennila Jaganathan, Redlin Jani Rajan, Krupanidhi Karunanithi   +7 more
wiley   +1 more source

Primary structure elements responsible for the conformational switch in the envelope glycoprotein gp120 from human immunodeficiency virus type 1: LPCR is a motif governing folding.

, 1993
J. Reed, V. Kinzel
openalex   +1 more source

55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages [PDF]

, 1997
Georges Herbein, Siamon Gordon
openalex   +1 more source

Associations between early‐life and in utero infections and cytomegalovirus‐positive acute lymphoblastic leukemia in children

International Journal of Cancer, Volume 152, Issue 5, Page 845-853, 1 March 2023., 2023
What's new? Cytomegalovirus (CMV) infection early in life likely contributes to the development of childhood acute lymphoblastic leukemia (ALL), owing to CMV‐induced alterations in immune function. In the present study, the relationship between risk of childhood ALL and exposure to CMV in utero or early life was investigated among children with ALL who
Rachel E. Gallant, Katti Arroyo, Catherine Metayer, Alice Y. Kang, Adam J. de Smith, Joseph L. Wiemels   +5 more
wiley   +1 more source

The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency.

, 1994
Michel Partiseti, Françoise Le Deist, Claire Hivroz, Alain Fischer, Henri Korn, Daniel Choquet   +5 more
openalex   +1 more source

Development of a Neutralizing Antibody Response during Acute Primary Human Immunodeficiency Virus Type 1 Infection and the Emergence of Antigenic Variants [PDF]

, 1998
Julie Lewis, Peter Balfe, Cath Arnold, Steve Kaye, Richard S. Tedder, Jane A. McKeating   +5 more
openalex   +1 more source

Rare Variants in Primary Immunodeficiency Genes and Their Functional Partners in Severe COVID-19. [PDF]

Biomolecules, 2023
Khadzhieva MB, Kolobkov DS, Kashatnikova DA, Gracheva AS, Redkin IV, Kuzovlev AN, Salnikova LE.   +6 more
europepmc   +1 more source

Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care. [PDF]

J Clin Immunol
Israni M, Alderson E, Mahlaoui N, Obici L, Rossi-Semerano L, Lachmann H, Avramovič MZ, Guffroy A, Dalm V, Rimmer R, Solis L, Villar C, Gennery AR, Skeffington S, Nordin J, Warnatz K, Korganow AS, Antón J, Cattalini M, Berg S, Soler-Palacin P, Campbell M, Burns SO, ESID Clinical Working Party, ERN RITA Transition Working Group Consortium.   +24 more
europepmc   +2 more sources

Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies [PDF]

, 1995
Els J. M. Hogervorst, J. de Jong, Anne‐Eva van der Wijk, Margreet Bakker, Marc van der Valk, Peter L. Nara, Jaap Goudsmit   +6 more
openalex   +1 more source